A randomized controlled trial of a vancomycin loading dose in children

Area of Science:

• Pediatric pharmacology
• Infectious disease pharmacotherapy
• Clinical pharmacokinetics

Background:

• Optimal intravenous vancomycin dosing remains debated.
• Early achievement of therapeutic trough concentrations is considered beneficial.
• This study investigated the impact of a vancomycin loading dose in children.

Purpose of the Study:

• To determine if a vancomycin loading dose increases the proportion of children achieving target trough concentrations 8 hours after therapy initiation.
• To assess the pharmacokinetic profile of vancomycin with and without a loading dose in pediatric patients.

Main Methods:

• Randomized controlled trial in hospitalized children aged 2-18 years.
• Comparison of a 30 mg/kg loading dose versus a 20 mg/kg conventional initial dose.
• Serum vancomycin concentrations measured pre-dose; pharmacokinetic parameters calculated.

Main Results:

• No significant difference in achieving target trough concentrations (15-20 mg/L) by the second dose (11% vs. 0%, P=0.17).
• Adequate systemic exposure (AUC/MIC > 400) in both groups.
• Higher incidence of Red Man Syndrome in the loading dose group (48% vs. 24%, P=0.06).

Conclusions:

• A vancomycin loading dose did not facilitate earlier achievement of therapeutic trough levels in this pediatric cohort.
• Vancomycin systemic exposure was sufficient with standard daily doses, even with lower measured troughs.
• The necessity of current high target trough concentrations for vancomycin in children warrants further investigation.